全球流感检测市场 - 市场规模（依细分市场）、占有率、监管、偿付、预测（~2033年）

本报告研究和分析了全球流感检测市场，提供了有关主要参与者和市场占有率、主要趋势、创新产品和技术以及竞争格局的资讯。

市场模型的主要内容如下。

市售流感测试和不断变化的竞争格局

• 对主要产业趋势的考察
• 依细分市场划分的流感检测市场年收入与市场前景（2015-2033年）
• 有关单位数量、平均售价和市场价值的市场级资料

全球、区域和国家层面的特定市场考察

• 依地区细分全球趋势的特定市场定性资讯和国家考察
• 流感检测市场的SWOT分析
• 流感检测市场竞争动态的考察与趋势

掌握包括医疗保健系统概述真实情况，促进市场了解。市场进入部分还提供有关偿付政策和监管环境的讯息，能够更深入地研究市场动态。

• 各国医疗保健系统概览
• 依国家/地区划分的偿付政策
• 各国医疗科技监理状况

目标公司

• Abbott Laboratories
• Cepheid Inc
• Quidel Corp
• Roche Diagnostics International Ltd
• DiaSorin Molecular LLC + Luminex Corp
• Becton Dickinson and Co
• Qiagen NV
• Thermo Fisher Scientific Inc
• bioMerieux SA
• Sekisui Diagnostics LLC
• 其他

Influenza Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize quantitative and qualitative market trends within In Vitro Diagnostics therapeutic area.

Influenza, also called flu or grippe, is an acute viral infection of the upper or lower respiratory tract that is marked by fever, chills, and a generalized feeling of weakness and pain in the muscles, together with varying degrees of soreness in the head and abdomen. Influenza viruses are categorized as types A, B, C, and D. These major types generally produce similar symptoms but are completely unrelated antigenically, so that infection with one type confers no immunity against the others. Influenza type A and B viruses cause the vast majority of influenza diseases in humans, and infection is preventable by vaccination.

Influenza tests are diagnostic tests used to detect the presence of the influenza virus in a patient's respiratory system. The choice of influenza test depends on a variety of factors, including the severity of the patient's illness, the timing of the test, and the availability of testing facilities.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Influenza Test and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total Influenza Tests market revenue by segment and market outlooks from

2015- 2033.

• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights:

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Influenza Tests market.
• Competitive dynamics insights and trends provided for Influenza Tests market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Abbott Laboratories, Cepheid Inc, Quidel Corp, Roche Diagnostics International Ltd, DiaSorin Molecular LLC + Luminex Corp, Becton Dickinson and Co, Qiagen NV, Thermo Fisher Scientific Inc, bioMerieux SA, Sekisui Diagnostics LLC, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Influenza Tests market place to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Influenza Tests market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Influenza Tests market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
• Track device sales in the global and country-specific Influenza Tests market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.